miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

BRD7 Suppresses Invasion and Metastasis in Breast Cancer by Negatively Regulating YB1-induced Epithelial-Mesenchymal Transition

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2020English

Hsa‑miR‑24 Suppresses Metastasis in Nasopharyngeal Carcinoma by Regulating the C‑Myc/Epithelial‑mesenchymal Transition Axis

Oncology Reports
MedicineCancer ResearchOncology
2018English

Hedgehog Signaling, Epithelial-To-Mesenchymal Transition and miRNA (Review)

International Journal of Molecular Medicine
MedicineGenetics
1998English

IKK Inhibitor Suppresses Epithelial-Mesenchymal Transition and Induces Cell Death in Prostate Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

TGF-β-induced Transgelin Promotes Bladder Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition and Invadopodia Formation

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

TRIM37 Promotes Cell Invasion and Metastasis by Regulating SIP1-mediated Epithelial–mesenchymal Transition in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Fas Signaling Promotes Motility and Metastasis Through Epithelial–mesenchymal Transition in Gastrointestinal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy